Novo Nordisk competitors

Novo Nordisk Competitors include Gilead Sciences, Amgen, Abbott and Aradigm.
Add company...
Novo Nordisk
Novo Nordisk is a healthcare company and a world leader in diabetes care.
Gilead Sciences
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
Amgen
Amgen engages in the development of human therapeutic products in supportive of cancer care, inflammation, nephrology and bone diseases.
Abbott
Abbott is a genomic disease management company that develops and markets clinical laboratory products.
Aradigm
Aradigm is a pharmaceutical company focused on the development of drugs for the treatment of severe respiratory diseases.
Founding Date
Founding Date
1923
Founding Date
1987
Founding Date
1980
Founding Date
1991
Founding Date
1991
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Bagsvaerd, DK HQ
Mississauga, CA
Beijing, CN
Mainz, DE
Bangalore, IN
Tokyo, JP
Jersey, JE
see more
Locations
Foster City, US HQ
Fremont, US
Oceanside, US
San Dimas, US
Branford, US
Seattle, US
Locations
Thousand Oaks, US HQ
Sydney, AU
North Ryde, AU
Vienna, AT
Brussels, BE
São Paulo, BR
Burnaby, CA
see more
Locations
Illinois City, US HQ
Sao Paulo, BR
Québec, CA
Beijing, CN
Shanghai, CN
Wiesbaden, DE
Tokyo, JP
see more
Locations
Hayward, US HQ
Employees
Employees
42,0761% increase
Employees
9,000
Employees
20,8008% increase
Employees
99,00032% increase
Employees
2344% increase
Valuation ($)
Valuation ($)
104.4 b
Valuation ($)
96.1 b
Valuation ($)
131.2 b
Valuation ($)
119.5 b
Valuation ($)
18.2 m
Facebook likes
Facebook likes
523.1 k
Facebook likes
5.4 k
Facebook likes
N/A
Facebook likes
193.1 k
Facebook likes
N/A
Twitter followers
Twitter followers
25.8 k
Twitter followers
27 k
Twitter followers
65.4 k
Twitter followers
61.1 k
Twitter followers
16

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$26.1b (FY, 2017)
Revenue (est.)
$23b (FY, 2016)
Revenue (est.)
$27.4b (FY, 2017)
Revenue (est.)
$14.5m (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
$4.4b (FY, 2017)
Cost of goods
$4.2b (FY, 2016)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$21.7b (FY, 2017)
Gross profit
$18.8b (FY, 2016)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
N/A
Net income
$4.6b (FY, 2017)
Net income
$7.7b (FY, 2016)
Net income
N/A
Net income
N/A

Operating

Phase III Trials Products
Phase III Trials Products
3 (FY, 2016)
Phase III Trials Products
6 (FY, 2016)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Products
Products
N/A
Products
25 (FY, 2016)
Products
N/A
Products
1.5 k (FY, 2016)
Products
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 175.5m
Total funding raised
$ 6.8m
Total funding raised
$ 27.1m
For sources of this data, please see the company profileDownload Excel

View company profiles

Gilead Sciences
HQ
Foster City, US
Employees
9,000

Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.

View company
Amgen
HQ
Thousand Oaks, US
Employees
20,800↑ 8% increase

Amgen engages in the development of human therapeutic products in supportive of cancer care, inflammation, nephrology and bone diseases.

View company
Abbott
HQ
Illinois City, US
Employees
99,000↑ 32% increase

Abbott is a genomic disease management company that develops and markets clinical laboratory products.

View company
Aradigm
HQ
Hayward, US
Employees
23↑ 44% increase

Aradigm is a pharmaceutical company focused on the development of drugs for the treatment of severe respiratory diseases.

View company